CAPITOL STRATEGIES, LLC

Lobbying for BIOLAB HOLDINGS, INC. · Biotechnology company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Arizona · House · Senate · $20,000.00 income · posted Jan 19, 2026

Bills named in this filing 1

Lobbying activity 2

Medicare/Medicaid

Skin substitute issues

Health Issues

H.R. 5768 - Skin Substitute Access and Payment Reform Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.